Zentalis
An Associate Medical Director leads the medical review and evaluation of safety data for a clinical oncology company developing a WEE1 inhibitor for ovarian cancer. The role involves assessing individual case safety reports, conducting signal detection, and ensuring regulatory compliance within the global pharmacovigilance team.
Zentalis Pharmaceuticals is a clinical-stage oncology company focused on developing azenosertib, a first-in-class oral WEE1 kinase inhibitor, for Cyclin E1-positive platinum-resistant ovarian cancer and other tumor types. The company is advancing azenosertib through late-stage, registration-intended clinical trials, including the Phase 3 ASPENOVA trial, using a biomarker-directed approach to provide a non-chemotherapy targeted therapy option. Zentalis engages the investor and medical communities through detailed pipeline, financial, and governance resources from its headquarters in San Diego, CA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zentalis.
Zentalis didn’t post a salary, so this is our estimate from similar listings.
15% above the average for this role
Medical Safety Physician, Pharmacovigilance
Verastem
Pharmacovigilance Physician
Venesco
Associate Medical Director, Global Safety Medical Review
alnylam
Director Drug Safety & Pharmacovigilance Medical Safety
Acadia Pharmaceuticals Inc.
Medical Safety Physician
spectraforce
Associate Medical Safety Director - Sponsor Dedicated
lifelancer